Article

Breast cancer survivors needed

Author(s):

It's been reported that more than half of survivors feel they didn't have all the information they needed to transition from treatment into survivorship. Many organizations are trying to address this need, especially as the population of survivors continues to grow. Army of Women is one organization that is tackling this issue by sponsoring a study to understand the best way to empower breast cancer survivors with the information they need. The "Pathways to Recovery After Breast Cancer" study is sponsored by the National Cancer Institute's Cancer Information Service and the Army of Women to find out the best way to provide post-treatment education. They are looking for 1000 participants, but only have about 600 registered, so if you want to help, here are the qualifications: •You were diagnosed with Stage I, II, or III breast cancer.•You have completed your primary breast cancer treatment within the last six months OR are about to complete treatment within the next month. "Primary" treatment includes surgery and/or chemotherapy and/or radiation. Although it is not required that you are taking any drugs, women who have completed or are about to complete primary treatment, but are taking Herceptin, Tamoxifen, and other such drugs, are eligible. •You have never been diagnosed with another cancer (breast cancer is the only invasive cancer you have had).•You are over 18 years old.•You are able to speak and understand English.•You live in the United States.•You have access to a computer. If you qualify, sign up here. And if you don't qualify but are interested in other studies, check out the "current studies" on the Army of Women website. Every little bit helps in the battle against cancer.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.
Image of doctor with text.
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to advancing kidney cancer care.
Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly.
Mark Daniels, 83, credits CAR T-cell therapy and compassionate care for helping him overcome lymphoma and endure the isolating treatment toll.
An early study of BGB-16673 for hard-to-treat leukemia found that side effects were manageable with no new safety concerns.
Image of woman with text.
Image of goy, and text.
Related Content